- Brand names:
- Pharmaceutical Company:
- Condition/Indication:
- Meeting Date: November 2015
- Public Summary Document (PSD) November 2015 PBAC Meeting - PDF
- Public Summary Document (PSD) November 2015 PBAC Meeting - Word
Empagliflozin – November 2015
Empagliflozin: oral tablet, 10mg, 25mg, Jardiance® (triple oral therapy)
Last updated
4 March 2016
